Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00447811 · ClinicalTrials.gov registry record · Phase 1
Study Evaluating MOA-728 in Subjects on Stable Methadone Maintenance
A Phase 1 study of Methadone-maintenance Subjects, sponsored by Bausch Health Americas.
- Completed
- Registry status
- Phase 1
- Development phase
- 1
- Study location
NCT00447811: Completed Phase 1 study of Methadone-maintenance Subjects, sponsored by Bausch Health Americas.
NCT00447811 is a Phase 1 study of Methadone-maintenance Subjects that has completed, run by Bausch Health Americas. The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00447811, a Phase 1 study of Methadone-maintenance Subjects, has completed, sponsored by Bausch Health Americas.
- COMPLETED
- Registry status
- Phase 1
- Development phase
- 1
- Study location
Study Summary
This is a study to evaluate the safety, tolerability, pharmacokinetics, and pharmacodynamics of MOA-728 in subjects on stable methadone maintenance.
Conditions Studied
Interventions
- DRUG MOA-728
Study Locations (1)
New Jersey
- - Willingboro
Trial Details
| Field | Value |
|---|---|
| Start Date | 2007-03 |
| Est. Completion | 2007-05 |
| Phase | Phase 1 |
What the finished NCT00447811 record still lists
NCT00447811 is an interventional study that assigns participants to a tested intervention. An enrollment target was not published in the registry record, which is common for early-stage or observational entries.
The record links to 1 condition, with Methadone-maintenance Subjects appearing as the primary indexed condition, and to 1 intervention - of which MOA-728 is the first listed.
NCT00447811 reports a single indexed study location in New Jersey.
Frequently Asked Questions
What is clinical trial NCT00447811 about?
NCT00447811 is a clinical study titled "Study Evaluating MOA-728 in Subjects on Stable Methadone Maintenance". This is a study to evaluate the safety, tolerability, pharmacokinetics, and pharmacodynamics of MOA-728 in subjects on stable methadone maintenance.
What is the current status of trial NCT00447811?
This trial is currently completed. It is a Phase 1 study. The study started on 2007-03. Estimated completion is 2007-05.
What conditions does trial NCT00447811 study?
This clinical trial studies the following conditions: Methadone-maintenance Subjects.
What interventions are being tested in trial NCT00447811?
The interventions under investigation include: MOA-728 (DRUG).
Who is sponsoring clinical trial NCT00447811?
This trial is sponsored by Bausch Health Americas, which has 168 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT00447811 being conducted?
This trial has 1 study location across New Jersey. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia